<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Balamuthia mandrillaris Meningoencephalitis in an Immunocompetent Patient: An Unusual Clinical Course and a Favorable Outcome

pmid: 15043486
Balamuthia mandrillaris Meningoencephalitis in an Immunocompetent Patient: An Unusual Clinical Course and a Favorable Outcome
Abstract Balamuthia mandrillaris meningoencephalitis is a rare but often fatal infection; only 2 survivors have been reported to date worldwide. We report the case of an apparently immunocompetent patient (72-year-old woman) who developed several episodes of seizures without prior history of respiratory or skin infections. Magnetic resonance imaging with contrast revealed 2 ring-enhancing lesions, one in the right precentral region and the other in the left posterotemporal region. Open biopsy revealed Balamuthia encephalitis. The patient was treated with combination antibiotics (pentamidine, 300 mg intravenously once a day; sulfadiazine, 1.5 g 4 times a day; fluconazole, 400 mg once a day; and clarithromycin, 500 mg 3 times a day) and was discharged home. There have been no significant neurological sequelae at this writing (6 months after biopsy). We present this case with unusual clinical course to raise awareness of this infectious disease, which may have a more favorable outcome if diagnosed and treated in its early states.
- Centers for Disease Control and Prevention United States
- State University of New York at Potsdam United States
- University of Chicago United States
- SUNY Upstate Medical University United States
Brain Neoplasms, New York, Sulfadiazine, Central Nervous System Protozoal Infections, Epilepsy, Partial, Motor, Opportunistic Infections, Magnetic Resonance Imaging, Diagnosis, Differential, Soil, Meningoencephalitis, Clarithromycin, Animals, Humans, Lobosea, Drug Therapy, Combination, Female, Fluconazole, Immunocompetence, Pentamidine, Aged
Brain Neoplasms, New York, Sulfadiazine, Central Nervous System Protozoal Infections, Epilepsy, Partial, Motor, Opportunistic Infections, Magnetic Resonance Imaging, Diagnosis, Differential, Soil, Meningoencephalitis, Clarithromycin, Animals, Humans, Lobosea, Drug Therapy, Combination, Female, Fluconazole, Immunocompetence, Pentamidine, Aged
17 Research products, page 1 of 2
- 2020IsAmongTopNSimilarDocuments
- 2013IsAmongTopNSimilarDocuments
- 2022IsAmongTopNSimilarDocuments
- 2010IsAmongTopNSimilarDocuments
- 2014IsAmongTopNSimilarDocuments
- 2022IsAmongTopNSimilarDocuments
- 2004IsAmongTopNSimilarDocuments
- 2007IsAmongTopNSimilarDocuments
- 2020IsAmongTopNSimilarDocuments
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).102 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%